Estee Lauder Companies (The) (EL) Earnings Date & Reports
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%)... Show more
EL is expected to report earnings to fall 64.65% to 32 cents per share on August 19
Estée Lauder (EL) Fiscal 2026 Third Quarter Earnings Recap: Beats Estimates and Raises Outlook
Key Takeaways
- Net sales rose 5% year-over-year to $3.712 billion, edging past consensus estimates of about $3.70 billion.
- Adjusted diluted EPS (earnings per share) surged 40% to $0.91, well above the $0.66 consensus.
- Adjusted operating margin expanded 360 basis points to 15.0%, fueled by gross margin gains and cost efficiencies from the Profit Recovery and Growth Plan (PRGP).
- Fragrance net sales grew 10% organically, driven by luxury brands like Le Labo and KILIAN PARIS.
- Company raised FY2026 guidance, now expecting ~3% organic sales growth and adjusted EPS of $2.35-$2.45.
- Shares rose post-earnings, reflecting investor approval of the results and upbeat outlook.
Earnings Context and Why It Matters
Estée Lauder's Fiscal 2026 Third Quarter results, for the period ended March 31, 2026, underscore the progress of its Beauty Reimagined strategy and PRGP amid a challenging prestige beauty environment. Investors closely watched for signs of sustained recovery in Mainland China, margin expansion, and execution on cost savings. These earnings are pivotal as the company aims to restore growth after prior years of declines, with implications for share gains in key markets like skincare and fragrance. Strong performance here signals potential stabilization, influencing valuation in a sector facing tariff pressures and shifting consumer trends.
Net sales reached $3.712 billion, up 5% reported and 2% organically from $3.550 billion a year ago, slightly beating consensus forecasts. GAAP diluted EPS fell 45% to $0.24, reflecting higher restructuring charges and a $84 million securities settlement loss contingency. However, adjusted diluted EPS climbed 40% to $0.91, crushing the $0.66 estimate, thanks to operational leverage.
Gross margin improved 140 basis points to 76.4%, offsetting tariffs and inflation via PRGP efficiencies. Adjusted operating income jumped 38% to $557 million, with margin up 360 basis points to 15.0%—exceeding expectations on skincare stabilization and fragrance momentum. Regionally, EUKEM and Asia/Pacific showed gains, led by 6% organic growth in Mainland China. Fragrance outperformed with 10% organic growth, while skincare was flat organically.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your stock discovery process.
Market Reaction and Investor Sentiment
Estée Lauder shares jumped following the Q3 release on May 1, 2026, as the adjusted EPS beat and guidance raise alleviated concerns over profitability. The market interpreted robust margin expansion and PRGP progress positively, despite GAAP headwinds from one-time charges. Sentiment improved on evidence of China recovery and fragrance strength, though tariff risks lingered. Trading volume spiked, with the stock gaining amid broader optimism for the sector.
Forward Outlook and Key Factors to Monitor
Estée Lauder raised its Fiscal 2026 guidance, targeting approximately 3% organic net sales growth at the high end of its prior range, adjusted operating margin of 10.7%-11.0% (about 300 basis points expansion), and adjusted diluted EPS of $2.35-$2.45, up from previous $2.05-$2.25. This reflects PRGP momentum, with expected annual benefits of $1.0-$1.2 billion and net position reductions of 9,000-10,000 roles, mostly complete by FY2027.
Investors should track Q4 execution amid ~$100 million tariff headwinds (half mitigated) and Middle East disruptions diluting sales by ~2% and EPS by $0.06. Early FY2027 view projects 3%-5% sales growth and 12.5%-13.0% adjusted operating margin, assuming prestige beauty acceleration and no geopolitical worsening.
Key monitors include Mainland China travel retail recovery, skincare innovation uptake (e.g., La Mer, Estée Lauder launches), fragrance momentum, and Beauty Reimagined distribution expansions like Amazon and TikTok Shop. PRGP savings realization and gross margin trends versus inflation will be critical.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Advertisement
General Information
a company which offers skin care, makeup, fragrance and hair care products
Industry HouseholdPersonalCare